Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization

BACKGROUND: Stereotactic ablative radiotherapy (SABR) can deliver tumoricidal doses and achieve long-term control in early hepatocellular carcinoma (HCC). However, limited studies have investigated the safety and effectiveness of SABR in patients with advanced diseases that is unsuitable for transar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Med Oncol
Main Authors: Lee, Hsin-Lun, Tsai, Jo-Ting, Chen, Chun-You, Lin, Ying-Chun, Ho, Chin-Beng, Ting, Lai-Lei, Kuo, Chia-Chun, Lai, I-Chun, Lin, Chun-Yu, Tang, Jui-Hsiang, Huang, Yu-Min, Kao, Wei-Yu, Cheng, Sheng-Wei, Shen, Chia-Ning, Chen, Shang-Wen, Chiou, Jeng-Fong
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Early Diagnosis and Therapeutic Advances for Liver Cancer: From Bench to Bedside
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6893933/
https://ncbi.nlm.nih.gov/pubmed/31839809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919889002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados